Literature DB >> 9639672

Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease.

M Ciotti1, F Chen, F F Rubaltelli, I S Owens.   

Abstract

Mutations at the bilirubin UDP-glucuronosyltransferase (transferase) gene in a severely hyperbilirubinemic Crigler-Najjar (CN) type I individual was compared with that in a moderately hyperbilirubinemic CN II individual. The CN-I (CF) patient in this study sustained a TATA box insertional mutation which was paired with a coding defect at the second allele, unlike all coding defects previously seen in CN-I patients. The sequence of the mutant TATA box, [A(TA)8A], also seen in the CN-II patient, was compared with that at the wild-type box, [A(TA)7A]. Transcriptional activity with [A(TA)8A] was 10-15% that with the wild-type box when present in the -1.7 kb upstream regulatory region (URR) of the bilirubin transferase UGT1A1 gene which was fused to the chloramphenicol acetyl transferase reporter gene, pCAT 1.7H, and transfected into HepG2 cells. Also, a construct with a TA deletion, [A(TA)6A], was prepared and used as a control; transcriptional activity was 65% normal. The coding region defect, R336W, seen in CF (CN-I) was placed in the bilirubin transferase UGT1A1 [HUG-Br1] cDNA, and its corresponding protein was designated UGT1A1*32. The UGT1A1*32 protein supported 0-10% normal bilirubin glucuronidation when expressed in COS-1 cells. The I294T coding defect seen at the second allele in SM (CN-II) generated the UGT1A1*33 mutant protein which supported 40-55% normal activity with a normal Km (2.5 microM) for bilirubin. The hyperbilirubinemia seen in SM decreased in response to phenobarbital treatment, unlike that seen in CF. Parents of the patients were carriers of the respective mutations uncovered in the offspring. The TATA box mutation paired with a deleterious missense mutation is, therefore, completely repressive in the CN-I patient, and is responsible for a lethal genotype/phenotype; but when homozygous, i.e. paired with itself, as previously reported in the literature, it is far less repressive and generates the mild Gilbert's phenotype.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9639672     DOI: 10.1016/s0925-4439(98)00030-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Transcriptional activation by bidirectional RNA polymerase II elongation over a silent promoter.

Authors:  Olivier Leupin; Catia Attanasio; Samuel Marguerat; Myriam Tapernoux; Stylianos E Antonarakis; Bernard Conrad
Journal:  EMBO Rep       Date:  2005-10       Impact factor: 8.807

2.  UGT1A1 and UGT1A9 functional variants, meat intake, and colon cancer, among Caucasians and African-Americans.

Authors:  Hugo Girard; Lesley M Butler; Lyne Villeneuve; Robert C Millikan; Rashmi Sinha; Robert S Sandler; Chantal Guillemette
Journal:  Mutat Res       Date:  2008-07-16       Impact factor: 2.433

Review 3.  Uridine 5'-diphospho-glucronosyltrasferase: Its role in pharmacogenomics and human disease.

Authors:  Celia N Sanchez-Dominguez; Hugo L Gallardo-Blanco; Mauricio A Salinas-Santander; Rocio Ortiz-Lopez
Journal:  Exp Ther Med       Date:  2018-05-18       Impact factor: 2.447

4.  Prediction of deleterious non-synonymous single-nucleotide polymorphisms of human uridine diphosphate glucuronosyltransferase genes.

Authors:  Yuan Ming Di; Eli Chan; Ming Qian Wei; Jun-Ping Liu; Shu-Feng Zhou
Journal:  AAPS J       Date:  2009-07-02       Impact factor: 4.009

5.  Transcriptional regulation of human UGT1A1 gene expression through distal and proximal promoter motifs: implication of defects in the UGT1A1 gene promoter.

Authors:  Junko Sugatani; Kousuke Mizushima; Makoto Osabe; Kasumi Yamakawa; Satoru Kakizaki; Hitoshi Takagi; Masatomo Mori; Akira Ikari; Masao Miwa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-01-03       Impact factor: 3.000

6.  A novel information retrieval model for high-throughput molecular medicine modalities.

Authors:  Firas H Wehbe; Steven H Brown; Pierre P Massion; Cynthia S Gadd; Daniel R Masys; Constantin F Aliferis
Journal:  Cancer Inform       Date:  2009-02-09

7.  Establishment of the experimental procedure for prediction of conjugation capacity in mutant UGT1A1.

Authors:  Yutaka Takaoka; Atsuko Takeuchi; Aki Sugano; Kenji Miura; Mika Ohta; Takashi Suzuki; Daisuke Kobayashi; Takuji Kimura; Juichi Sato; Nobutaro Ban; Hisahide Nishio; Toshiyuki Sakaeda
Journal:  PLoS One       Date:  2019-11-15       Impact factor: 3.240

8.  Adaptive evolution of multiple-variable exons and structural diversity of drug-metabolizing enzymes.

Authors:  Can Li; Qiang Wu
Journal:  BMC Evol Biol       Date:  2007-05-02       Impact factor: 3.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.